Importance Programmed cell death 1 (PD-1) inhibitor–related pneumonitis is a rare but
clinically serious and potentially life-threatening adverse event. Little is known about its …

Although most lung cancers are a result of smoking, approximately 25% of lung cancer
cases worldwide are not attributable to tobacco use, accounting for over 300,000 deaths …

Lung cancer is the leading cause of cancer-related death in the United States. Although
tobacco smoking accounts for the majority of lung cancer, approximately 10% of patients …

Background Better information on lung cancer occurrence in lifelong nonsmokers is needed
to understand gender and racial disparities and to examine how factors other than active …

Purpose Tobacco smoke is a definite causative agent for lung cancer. It is increasingly being
recognized that never-smokers can be afflicted with non–small-cell lung cancer (NSCLC) …

Background: Recently, immune checkpoint inhibitors (ICIs) have been proved one of the
most promising anti-cancer therapy, series clinical trials have confirmed their efficacy. But …

It is estimated that approximately 25% of all lung cancer cases are observed in never-
smokers and its incidence is expected to increase due to smoking prevention programs …

Simple Summary The standard of care for patients with stage III non-small cell lung cancer is
concurrent chemoradiotherapy followed by maintenance durvalumab based on outcomes …

BACKGROUND: The objectives of this study were to determine the proportions of major
oncogenic alterations and to examine survival in genotype‐specific subsets of never …

The aim of this study was to determine the distribution of known oncogenic driver mutations
in female never-smoker Asian patients with lung adenocarcinoma. We analyzed 214 …